About the Authors
- Matthew E. Witek
-
Affiliation Department of Radiation Oncology, Kimmel Cancer Center & Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Adam E. Snook
-
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Jieru E. Lin
-
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Erik S. Blomain
-
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Bo Xiang
-
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Michael Magee
-
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Scott A. Waldman
-
* E-mail: scott.waldman@jefferson.edu
Affiliation Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
Competing Interests
SAW is the Chair of the Data Safety Monitoring Board for the C-Cure Trial™ sponsored by Cardio Biosciences, and the Chair (uncompensated) of the Scientific Advisory Board of Targeted Diagnostics and Therapeutics, Inc., which provided research funding that, in part, supported this work and has a license to commercialize inventions related to this work. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MEW AES JEL ESB SAW. Performed the experiments: MEW AES JEL ESB MM BX. Analyzed the data: MEW AES JEL ESB SAW. Contributed reagents/materials/analysis tools: MEW AES JEL ESB SAW. Wrote the paper: MEW ESB SAW.